Wyoming Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Tech Reporter.

Press releases published on June 22, 2026

4 hours ago

Novel Key Terms For Managing CIDP Published in Neurology® Journal

Indeterminate GlobeNewswire

4 hours ago

Refinity Secures Exclusive License to PNNL Catalyst Technology to Convert Olefins into Circular Hydrocarbon Liquids for SAF Production

Indeterminate GlobeNewswire

4 hours ago

EagleNXT Secures Order of eBee VISION ISR and eBee TAC Systems from Asia Pacific Customer

Indeterminate GlobeNewswire

4 hours ago

Medidata Unveils New Academic Board to Bridge the Gap Between Research and Patient Care

Indeterminate GlobeNewswire

4 hours ago

Azure Maps Gen1 Pricing Customers To Be Migrated To Gen2 Pricing in September 2026, A 9x Cost Increase

Indeterminate GlobeNewswire

4 hours ago

Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition

Indeterminate GlobeNewswire

4 hours ago

Hyperion DeFi and Blockdaemon Partner to Expand Institutional Hyperliquid Staking Infrastructure

Indeterminate GlobeNewswire

4 hours ago

Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.

Indeterminate GlobeNewswire

4 hours ago

Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum

Indeterminate GlobeNewswire

4 hours ago

Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome

Indeterminate GlobeNewswire

4 hours ago

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants

Indeterminate GlobeNewswire

4 hours ago

Atsena Therapeutics Doses First Patient and Reports Rapid Early Enrollment in Pivotal Trial of ATSN-201 for X-Linked Retinoschisis

Indeterminate GlobeNewswire

4 hours ago

Prolium Bioscience Announces First Patient Dosed in its Multinational, Phase 1/2 Study of PRO-203 in Systemic Sclerosis, and Last Patient, Last Visit in an Investigator-Led Study of PRO-203 in Refractory Lupus Nephritis

Indeterminate GlobeNewswire

4 hours ago

Veea Strengthens Executive Leadership Team to Accelerate its Commercial Growth and Market Expansion

Indeterminate GlobeNewswire

4 hours ago

Rezolve Ai Powers New Mashreq and Visa Everyday Cashback Program, Bringing AI-Enabled Card Linked Offers to UAE Cardholders

Indeterminate GlobeNewswire

4 hours ago

Genius Group Buys Back 6,037,851 Company Shares

Indeterminate GlobeNewswire

4 hours ago

Quantum Cyber Issues Letter to Shareholders

Indeterminate GlobeNewswire

4 hours ago

BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026

Indeterminate GlobeNewswire

4 hours ago

Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026

Indeterminate GlobeNewswire

4 hours ago

Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds

Indeterminate GlobeNewswire